A pilot study to assess the safety and tolerability of oral xanthohumol in humans with Crohn's Disease, to identify a biological signature of xanthohumol exposure, and to characterize the role of xanthohumol metabolism by intestinal microorganisms in that signature within adults with Crohn's Disease.
